Developed during the 1990s as a composite of four foundational broadleaf indica lineages, Black Domina combines the compact structure and resin yield of Northern Lights, the sedative depth of Ortega, the heavy resin production of Hash Plant, and the rugged hardiness of Afghan landraces. Historically nicknamed “The Black Lady of Cannabis” due to its dark, midnight-violet pigmentation, the cut was selected specifically for structural vigor, high gland-to-leaf ratios, and pronounced physical therapeutic properties.

Grown in pharmaceutical-grade European and international indoor facilities under GACP guidelines, cultivation parameters are managed to maximize calyx swelling and protect delicate trichome heads from mechanical degradation. In European prescription corridors—particularly Germany under the CanG framework, the UK, and Poland—Black Domina is commonly prescribed for severe treatment-resistant insomnia, chronic nocturnal pain, musculoskeletal hypertonicity, and spasticity disorders.

Technical Specifications & Certificate of Analysis (CoA)

Sensory & Terpene Profile Breakdown

• Spiced Afghan Hash & Black Pepper: Dominated by high concentrations of Beta-Caryophyllene and Humulene, yielding an upfront bouquet of warm cracked peppercorn, sandalwood, and traditional pressed hashish.

• Damp Earth & Pine Forest Floor: Heavy Myrcene and Alpha-Pinene lend a cooling herbal undertone of rich forest loam, damp cedar, and fresh pine needles upon inhalation.

• Subtle Dark Fruit & Blackberry: A faint, sweet berry compote and molasses note lingers on the palate, inherited from the Ortega and Northern Lights lineage.

• Visual Morphology: Dense, rounded calyx clusters displaying forest-green buds interwoven with dark plum-to-charcoal sugar leaves, fiery reddish-amber pistils, and an opaque exterior coating of stalked glandular trichomes.

European Compliance, Quality Assurance & Distribution

• EU-GMP Quality Assurance: Cured, trimmed, and packaged in certified pharmaceutical cleanrooms under EU-GMP parameters, ensuring lot-to-lot homogeneity, validated stability, and zero adulteration.

• Accredited Laboratory Testing: Validated by independent ISO/IEC 17025 accredited laboratories in alignment with Ph. Eur. Chapter 5.1.8 criteria for heavy metals (lead, cadmium, mercury, arsenic), agrochemical residues, mycotoxins, and microbial bioburden.

• Schengen Cross-Border Logistics: Supported by a complete regulatory documentation suite, including batch-specific CoAs, Active Pharmaceutical Ingredient (API) release files, and validated bilateral narcotics import/export authorizations within the European Union.

• Pharmaceutical Packaging: Supplied in tamper-evident, child-resistant, nitrogen-flushed pharmaceutical pouches or medical-grade amber containers equipped with integrated 62% humidity regulators to prevent volatile monoterpene evaporation and maintain target moisture levels during transit.